Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gemma Strickland

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Clinical Rheumatology|May 17, 2012
Predictors of health-related quality of life and fatigue in systemic sclerosis: evaluation of the EuroQol-5D and FACIT-F assessment toolsGemma Strickland, John Pauling, Charlotte Cavill, et al.
Clinical Rheumatology|July 2, 2013
Mortality in systemic sclerosis-a single centre study from the UKGemma Strickland, John Pauling, Charlotte Cavill, et al.
Rheumatology (Oxford, England)|December 22, 2010
Retinal vascular calibre is altered in patients with rheumatoid arthritis: a biomarker of disease activity and cardiovascular risk?Sharon Van Doornum, Gemma Strickland, Ryo Kawasaki, et al.
Arthritis Care & Research|August 18, 2019
Can Patient-Reported Symptoms Be Used to Measure Disease Activity in Systemic Sclerosis?Laura Ross, Wendy Stevens, Michelle Wilson, et al.
Clinical Rheumatology|July 23, 2020
Performance of the 2017 EUSTAR activity index in an scleroderma cohortLaura Ross, Wendy Stevens, Michelle Wilson, et al.
Arthritis Research & Therapy|February 16, 2019
Significance of anti-neutrophil cytoplasmic antibodies in systemic sclerosisJayne Moxey, Molla Huq, Susanna Proudman, et al.
Arthritis Care & Research|February 15, 2020
Clinical Features of Systemic Sclerosis-Mixed Connective Tissue Disease and Systemic Sclerosis Overlap SyndromesJessica L Fairley, Dylan Hansen, Susanna Proudman, et al.
Rheumatology (Oxford, England)|September 10, 2020
Occupational silica exposure in an Australian systemic sclerosis cohortShreeya Patel, Kathleen Morrisroe, Susanna Proudman, et al.
Clinical and Experimental Rheumatology|October 3, 2018
The role of inflammatory markers in assessment of disease activity in systemic sclerosisLaura Ross, Wendy Stevens, Candice Rabusa, et al.
Scientific Reports|October 18, 2019
IFNL3 genotype is associated with pulmonary fibrosis in patients with systemic sclerosisMayada Metwally, Khaled Thabet, Ali Bayoumi, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Clinical Rheumatology|May 17, 2012
Predictors of health-related quality of life and fatigue in systemic sclerosis: evaluation of the EuroQol-5D and FACIT-F assessment toolsGemma Strickland, John Pauling, Charlotte Cavill, et al.
Clinical Rheumatology|July 2, 2013
Mortality in systemic sclerosis-a single centre study from the UKGemma Strickland, John Pauling, Charlotte Cavill, et al.
Rheumatology (Oxford, England)|December 22, 2010
Retinal vascular calibre is altered in patients with rheumatoid arthritis: a biomarker of disease activity and cardiovascular risk?Sharon Van Doornum, Gemma Strickland, Ryo Kawasaki, et al.
Arthritis Care & Research|August 18, 2019
Can Patient-Reported Symptoms Be Used to Measure Disease Activity in Systemic Sclerosis?Laura Ross, Wendy Stevens, Michelle Wilson, et al.
Clinical Rheumatology|July 23, 2020
Performance of the 2017 EUSTAR activity index in an scleroderma cohortLaura Ross, Wendy Stevens, Michelle Wilson, et al.
Arthritis Research & Therapy|February 16, 2019
Significance of anti-neutrophil cytoplasmic antibodies in systemic sclerosisJayne Moxey, Molla Huq, Susanna Proudman, et al.
Arthritis Care & Research|February 15, 2020
Clinical Features of Systemic Sclerosis-Mixed Connective Tissue Disease and Systemic Sclerosis Overlap SyndromesJessica L Fairley, Dylan Hansen, Susanna Proudman, et al.
Rheumatology (Oxford, England)|September 10, 2020
Occupational silica exposure in an Australian systemic sclerosis cohortShreeya Patel, Kathleen Morrisroe, Susanna Proudman, et al.
Clinical and Experimental Rheumatology|October 3, 2018
The role of inflammatory markers in assessment of disease activity in systemic sclerosisLaura Ross, Wendy Stevens, Candice Rabusa, et al.
Scientific Reports|October 18, 2019
IFNL3 genotype is associated with pulmonary fibrosis in patients with systemic sclerosisMayada Metwally, Khaled Thabet, Ali Bayoumi, et al.
Pageof 1